Getting Paid in Equity: A Legal Guide for Celebrities, Athletes & Creators Taking Stock in Brand Deals

Getting Paid in Equity | LumaLex Law

November 7, 2026 · Dustin Robinson

Why Celebrities and Creators Are Trading Cash for Equity

Some of the biggest endorsement paydays of the last decade haven’t come from appearance fees. They’ve come from equity. When a brand that an athlete, actor, or creator helped build gets acquired, an ownership stake can be worth far more than a flat endorsement fee.

Brands understand this, too. Startups with limited cash increasingly offer stock, stock options, or LLC units in exchange for a celebrity’s name, image, likeness, social reach, or creative direction. Sometimes the talent serves as a brand ambassador. Sometimes they’re brought on as a creative director or advisor. In other cases, they may also invest their own money.

The potential upside is significant, but so are the risks. An equity grant isn’t simply a marketing contract with a stock bonus attached. It’s a securities transaction, a potential tax event, and a long-term business relationship. The terms you agree to at the beginning can determine whether your stake becomes valuable when the company sells or gets diluted, taxed, or forfeited along the way.

At LumaLex Law, we represent celebrities, athletes, influencers, and creators with millions of followers in these types of deals. This guide covers what we want every client to understand before accepting equity for an endorsement.

What Kind of Equity Are You Actually Being Offered?

“You’ll get 2% of the company” can mean very different things depending on how the deal is structured. The type of equity you’re offered affects your taxes, your risk, and ultimately what you may receive if the company succeeds.

These are the most common structures we see in talent deals:

Equity type What it is Typical tax treatment What to watch for
Restricted stock (common) Actual shares, usually subject to vesting Ordinary income on value when vested, unless a valid 83(b) election is made Missing the 30-day 83(b) deadline
Non-qualified stock options (NSOs) The right to buy shares later at a fixed “strike” price Generally ordinary income on the spread when exercised Exercise cost, short post-termination exercise windows
Incentive stock options (ISOs) Tax-favored options Potentially favorable capital gains treatment Only available to employees. Most talent are contractors, so ISOs usually aren’t available
Restricted stock units (RSUs) A promise to deliver shares later Generally ordinary income when shares are delivered Common at later-stage companies; upside depends on the company’s future value
LLC units / profits interests Ownership in an LLC; a profits interest generally shares in future growth Profits interests can often be received tax-free if structured correctly K-1s, phantom income, operating agreement terms
SAFEs / convertible notes Rights to future equity, often when you also invest cash Tax treatment depends on the instrument and transaction Valuation caps, discounts, MFN rights
Phantom equity / revenue share Cash compensation tied to company value or sales, rather than actual ownership Generally ordinary income when paid No voting or information rights; payment rights may change in a sale

Many deals combine several forms of compensation: a cash fee, a stock grant, a revenue royalty, and perhaps the right to invest in the next round. Each component should be evaluated and negotiated on its own terms.

9 Equity Terms Every Brand Ambassador Should Negotiate

The ownership percentage is usually what gets everyone’s attention, but the terms behind that number matter just as much.

  1. Percentage vs. share count. Get a fixed number of shares and confirm what percentage that represents on a fully diluted basis, including outstanding options, warrants, SAFEs, and convertible notes. A promised “2%” of issued shares can become much less once everything converts.

  2. Vesting tied to deliverables. Many equity grants vest over time, often two to four years. For talent, it may make more sense to tie vesting to specific deliverables, such as posts, campaigns, appearances, or product launches. Make sure performance is defined objectively rather than left entirely to the company’s discretion.

  3. Acceleration on a sale. If the company is acquired before your equity fully vests, what happens to the remaining shares? Single-trigger acceleration provides vesting upon the sale itself, while double-trigger acceleration requires the sale plus a qualifying termination. If your name and involvement helped build the brand’s value, acceleration is worth negotiating.

  4. What happens if the deal ends. Clarify what you keep if either party terminates the relationship, with or without cause. Pay close attention to clawbacks, company repurchase rights at cost, and short option exercise windows, which are often limited to 90 days.

  5. Anti-dilution and top-up rights. Common stock can be diluted when a company raises additional capital. Ask whether you can negotiate pro rata rights to invest in future rounds or a top-up provision that maintains your ownership percentage through an agreed milestone.

  6. Liquidation preferences. Investors holding preferred stock may get paid before common stockholders in a sale. In a modest exit, that can leave common shareholders with little or nothing. Understand where your equity sits in the payment structure before assigning value to it.

  7. Information rights. Ask for periodic financial statements and cap table updates. Without access to that information, it can be difficult to understand what your stake is worth or how your ownership has changed.

  8. Transfer restrictions, drag-along rights, and ROFR. These provisions can limit when, how, and to whom you can sell your shares. Understand the restrictions before assuming you’ll have access to liquidity.

  9. Strike price and 409A valuation. For options, the exercise price generally needs to meet applicable fair market value requirements under Section 409A. An outdated or missing valuation can create serious tax consequences.

The Tax Traps: Section 83, the 83(b) Election and QSBS

Equity received in exchange for services is generally treated as compensation for tax purposes. If the grant isn’t structured carefully, you could owe taxes on stock you cannot yet sell or miss out on a tax benefit worth a substantial amount of money.

Section 83: You Can Owe Tax on Paper Wealth

Under Section 83 of the Internal Revenue Code, stock received for services is generally taxed as ordinary income based on its fair market value. When stock is subject to vesting, the default rule typically taxes each portion as it vests, based on its value at that time.

If the company’s value increases significantly before your stock vests, your tax liability may increase as well, even if you haven’t received any cash from the investment.

The 83(b) Election: 30 Days, No Extensions

An 83(b) election allows you to recognize income based on the value of restricted stock at the time of transfer rather than waiting until it vests. When the stock’s value is still low, that can create a meaningful tax advantage. Future appreciation may then qualify for capital gains treatment when you sell.

The election must generally be filed with the IRS within 30 days of the stock transfer. Missing that deadline can eliminate the opportunity, which is why it’s one of the first things we review in talent equity deals.

Options: NSOs and Self-Employment Tax

Because many celebrities and creators work as independent contractors, they typically receive non-qualified stock options rather than incentive stock options.

Exercising an NSO generally triggers ordinary income on the difference between the exercise price and the stock’s fair market value. For independent contractors, that income may also be subject to self-employment tax. The timing of exercise can therefore have a significant impact on the overall economics of the deal.

QSBS: The Potential Tax-Free Exit

Stock in a qualifying C corporation may be eligible for Qualified Small Business Stock treatment under Section 1202. QSBS can be received in exchange for services, not just cash.

For qualifying stock issued after July 4, 2025, the exclusion is 50% after three years, 75% after four years, and 100% after five years, subject to the applicable requirements. The exclusion can reach $15 million in gain per issuer, or 10 times the qualifying basis if greater. The company must also satisfy the applicable $75 million gross-assets limitation when the stock is issued.

LLC units and unexercised options aren’t themselves QSBS. That is why the form and timing of your equity grant matter, particularly if you’re hoping to qualify for the exclusion later.

Holding Equity Through a Loan-Out or Holding Company

Many entertainers work through a loan-out corporation or LLC. Whether the equity is issued to you personally or to your entity can affect QSBS eligibility, state taxes, and estate planning.

This decision should be made before the grant documents are signed, not after. For talent based in Florida or Puerto Rico, residency and Act 60 planning may introduce additional considerations.

FTC and SEC Rules: Equity Is a “Material Connection”

Owning part of a company changes what you need to disclose when you promote it.

  • FTC Endorsement Guides. The FTC requires endorsers to clearly disclose material connections to a brand, including ownership interests. Saying “Proud co-owner” or “I’m an investor in this brand” can help communicate that relationship, but the disclosure should appear clearly in the actual promotional content, not be buried in a bio or a long list of hashtags. Both the brand and the endorser can face liability.

  • SEC Section 17(b). Promoting a security, such as a company’s stock, token, or investment offering, can trigger separate disclosure requirements. Federal law may require disclosure of the nature, source, and amount of compensation received for the promotion. The SEC has pursued enforcement actions against celebrities who promoted crypto assets without adequate disclosure. Promoting a company’s products and promoting its securities are two different activities with different legal implications.

  • How the company issues your equity. Private companies often rely on Rule 701 or another securities exemption when issuing equity to consultants and advisors. Rule 701 covers certain bona fide services, but not services connected to raising capital or promoting the company’s securities. The agreement should accurately describe the brand, creative, or advisory services you’re providing.

  • Regulated industries. Endorsements involving cannabis, telehealth, supplements, alcohol, peptides, and financial products may carry additional restrictions on health claims, age-gating, and advertising platforms. Having an ownership stake doesn’t protect you from liability for claims made in your name.

Protecting Your Name, Image and Likeness

Equity is only part of the deal. The other part is the company’s right to use your name, image, and likeness (NIL), which can sometimes extend beyond the working relationship itself.

  • Scope of the license. Define the products, channels, territories, and media in which the brand can use your NIL. Restrict use for unrelated product lines or advertising campaigns you haven’t approved.

  • Approval rights. Require written approval for content, products, or packaging that use your name or likeness.

  • AI and digital replicas. Address AI-generated likenesses, voice clones, and digital doubles explicitly, and require separate written consent and compensation for any permitted use.

  • Term and sell-off. When the relationship ends, the brand should stop using your NIL, subject to any narrowly defined sell-off period for existing inventory. Your equity should not require you to grant a perpetual license.

  • Exclusivity. Limit any non-compete or exclusivity provision to a clearly defined product category and time period so it doesn’t unnecessarily restrict future opportunities.

  • Mutual morals clauses. Brands often want the right to terminate a relationship if the talent becomes involved in a scandal. Consider negotiating a similar right if the company or its founders engage in conduct that could damage your reputation.

  • Indemnification and insurance. The company should be responsible for appropriate claims arising from its products. Consider requesting coverage under its product liability policy.

  • Union and agency rules. SAG-AFTRA members and agency-represented talent should confirm that any arrangement is consistent with applicable union rules and existing representation agreements.

Red Flags Before You Sign

If any of these appear in your term sheet, have counsel review them before moving forward:

  • The equity is promised in an email or side letter but never formally approved or granted

  • A percentage is quoted without a share count or fully diluted cap table

  • Vesting depends on deliverables that only the company decides you’ve satisfied

  • The company can repurchase vested shares at cost if you leave

  • You’re asked to promote the company as an investment opportunity

  • The NIL license is perpetual, worldwide, and irrevocable

  • No one has discussed an 83(b) election or 409A valuation

  • You’re told to “just sign the standard advisor agreement”

Frequently Asked Questions

Should I Take Equity Instead of Cash for an Endorsement?

Often, the best arrangement includes both. Cash provides immediate compensation and can help cover expenses and taxes, while equity gives you a chance to participate in the company’s future growth.

Because startups carry significant risk, accepting only equity is a much bigger bet. Consider the company’s funding, business traction, and the value your involvement could realistically contribute.

What Percentage of Equity Should a Celebrity Brand Ambassador Get?

There is no standard percentage. Advisor grants are often well below 1%, while a celebrity whose name or audience is central to the business may be able to negotiate a much larger stake.

The company’s stage, your audience size, the time commitment, exclusivity, and expected deliverables all play a role. Whatever percentage is offered, make sure it is calculated on a fully diluted basis.

How Is Equity Taxed for Influencers and Creators?

Equity received in exchange for services is generally treated as compensation and may be taxed as ordinary income when received or as it vests, depending on the type of grant.

Options have different tax treatment and are often taxed when exercised. An 83(b) election, when available and filed within the required 30-day period, may allow restricted stock to be taxed at an earlier, potentially lower value.

Do I Have to Disclose That I Own Part of a Brand I Promote?

Yes. Under the FTC’s Endorsement Guides, an ownership stake is a material connection that generally must be clearly disclosed when you promote the brand.

Can My Equity Be Taken Away If the Deal Ends?

It depends on your agreement. Unvested equity is often forfeited when the relationship ends, and some agreements allow the company to repurchase vested shares under specified conditions.

These rights should be negotiated and understood before signing.

Can Stock I Receive for Promotion Qualify for QSBS?

Potentially, yes. Stock received for services in a qualifying C corporation may be eligible for QSBS treatment under Section 1202.

If the applicable holding period and other requirements are satisfied, you may be able to exclude up to $15 million or more in qualifying gains from federal income tax, depending on your basis and the relevant limits.

How LumaLex Law Helps Talent Take Equity the Right Way

Entertainment lawyers understand endorsement agreements. Startup lawyers understand cap tables. But a deal involving both requires someone who can connect those pieces and understand the tax consequences as well.

LumaLex Law is led by Dustin Robinson, an attorney and CPA, venture fund general partner, and entrepreneur who has founded five companies. Our firm represents both high-growth startups and the celebrities, athletes, and creators they work with. That experience gives us an understanding of what brands can realistically offer and where talent may be leaving value on the table.

We help talent:

  • Evaluate the company, its cap table, and the actual value of the proposed equity

  • Negotiate equity, vesting, acceleration, and anti-dilution provisions

  • Structure grants with 83(b), QSBS, loan-out entities, and state tax planning in mind

  • Draft and negotiate NIL licenses, approval rights, and exit provisions

  • Understand and comply with applicable FTC and SEC disclosure requirements

Offered equity in a brand deal? Contact LumaLex Law to schedule a consultation before you sign.

This article is for general informational purposes only and is not legal or tax advice. Reading it does not create an attorney-client relationship. Tax rules change and depend on your specific facts. Consult a qualified attorney or tax advisor about your situation.

Share:

Facebook
X
LinkedIn

More Posts

Send Us A Message

Liliana Rivero | Lumalex Law

Liliana Rivero

Paralegal

With more than 15 years of professional experience, Liliana Rivero serves as a Paralegal and Administrative Assistant at LumaLex Law, where she provides comprehensive support to the firm’s attorneys and clients throughout every stage of the legal process. Recognized for her attention to detail, organization, and client-first approach, Liliana helps ensure matters are handled efficiently while delivering the responsive, high-quality service clients expect.

Raised in South Florida, Liliana earned her Associate of Arts in Paralegal Studies and her Bachelor of Arts in Criminal Justice. Throughout her career, she has worked across a broad range of industries and legal practice areas, including real estate, civil litigation, criminal defense, business law, and hospitality. This diverse background has given her a well-rounded perspective, exceptional organizational skills, and the ability to adapt to the unique needs of each client and matter.

Liliana believes that every step of her professional journey has prepared her for her current role. Her experience across multiple disciplines has strengthened her ability to anticipate challenges, communicate effectively, and support complex legal matters with professionalism, precision, and care.

At LumaLex Law, Liliana is proud to be part of a forward-thinking boutique law firm that values innovation, collaboration, and practical legal solutions. She is passionate about contributing to a team where achieving exceptional results is matched by an unwavering commitment to integrity, professionalism, and outstanding client service.

Bianca Lindau | Lumalex Law

Bianca Lindau

Senior Associate

Bianca Lindau is a Senior Associate at LumaLex Law, where her practice focuses on corporate transactions, venture financings, and commercial agreements for technology, healthcare, and emerging-industry clients. She regularly advises founders and growth-stage companies on entity formation, governance, M&A, and the negotiation of complex commercial contracts, including SaaS agreements, technology licenses, and joint development agreements.

Bianca brings nearly four years of transactional experience to her practice, having previously served as an Associate at a boutique corporate and IP law firm, where she advised technology companies and startups on a broad range of corporate and commercial matters, including stock purchase agreements, investor rights agreements, SAFEs, and IP-centric licensing and acquisition agreements. Her work has also touched on the evolving legal landscape around generative AI, including published writing on the topic and collaboration with companies developing AI-enabled legal tools. Bianca holds an LLM from Cornell Law School, where she was awarded the Cantwell Prize for Exemplary Student Research and a CALI Award in Contracts. She earned her German law degree (Diplom-Juristin) from Humboldt University Berlin and a Diploma in Legal Studies from King’s College London. She is admitted to practice in both Massachusetts and California. A native speaker of English, Spanish, and German, with proficiency in French, Bianca brings a global perspective to her work with clients and counterparties across jurisdictions. Outside the office, Bianca is an avid traveler who has visited every continent except Antarctica, and she is always seeking out new experiences, whether a new restaurant, unexpected hobbies, or an unfamiliar destination. She also enjoys staying active, channeling her creative side through needlepoint and clothing design, and spending time with her dog.

Ian Horowitz

Ian Horowitz

Of-Counsel
States Licensed: FL

Mr. Horowitz focuses his practice on estate planning, taxation, and business related matters, with advanced proficiency in estate, gift, federal income, and generation-skipping transfer taxation. His extensive knowledge in these areas enables him to craft tailored strategies that optimize tax efficiency and safeguard his clients’ assets. From crafting straightforward wills to designing complex domestic and foreign trusts, his commitment to preserving wealth and ensuring asset protection is unwavering.

In addition to his prowess in estate planning, Mr. Horowitz serves as a trusted advisor to businesses of all sizes from formation to sale assisting with drafting purchase and sale agreements, limited liability operating agreements, or other corporate documents. His counsel on entity formation and tax-efficient structures empowers entrepreneurs and corporations to make informed decisions that drive growth and prosperity.

Mr. Horowitz possesses a wealth of experience in international tax matters. He offers invaluable guidance to foreign clients navigating inbound business and real estate transactions in the United States. He is also recognized for his efficiency in helping individuals become bona fide residents of Puerto Rico under IRC Section 937. This specialized knowledge in tax strategies related to Puerto Rico’s unique tax laws positions him as a sought-after advisor for those seeking to take advantage of the favorable tax incentives offered by Puerto Rico.

Aggeliki Psonis

Aggeliki Psonis

Associate
States Licensed: NY, NJ. MA

A graduate of Boston University, with a JD from CUNY law school, Aggeliki focuses her practice on real estate transactions, estate planning and administration, business law and general litigation. She has extensive experience representing buyers, sellers, investors and business owners based in New York and internationally.

Aggeliki is admitted in the states of New York, New Jersey and Massachusetts, as well as in the Eastern and Southern Districts of New York. She is also a licensed Real Estate broker. She is a proud member of the Inspiring Women in Law League (IWILL) and the Hellenic Lawyers Association. She speaks fluent Greek and conversational French and Spanish. Aside from lawyering, she enjoys being a radio producer and performing artist.

Dallas Robinson, Of-Counsel

Dallas Robinson

Of-Counsel
States Licensed: FL

 

Dallas Robinson is an AV Preeminent-rated trial attorney who has dedicated his practice to representing injured people throughout Florida. Dallas has litigated and tried many different types of personal injury cases in numerous courthouses and venues in Florida. Dallas believes in prosecuting personal injury cases in a professional and aggressive manner, and has a clear track record of success in obtaining great financial compensation for his clients either through verdicts or settlements. Many lawyers advertise ‘trial experience,’ but have actually never seen the inside of a courtroom. Dallas has spent his entire career in the courtroom and litigating cases. This gives Dallas the real and true experience that it takes to strike fear in the hearts of insurance companies and obtain top financial compensation for his injured clients.

 

Dallas grew up in South Florida and attended Boston University where he played quarterback and defensive back for Boston University’s football team. Dallas graduated in 4 years with bachelor degrees in Classical Civilizations and History. He went straight to law school and attended University of Miami (FL) School of Law. Dallas graduated in 2002 with a Juris Doctorate degree and immediately passed the Florida Bar.

 

Dallas began his legal career representing businesses and insurance companies in workers’ compensation and personal injury cases. This gave him unique insight into exactly how insurance companies work and how they value cases. After achieving a high level of success in litigating these cases, Dallas moved on to representing the injured. Since that time, Dallas has obtained tens of millions of dollars in compensation for his clients through settlements and trial verdicts. Dallas is a member of the Multi-Million Dollar Advocates Forum which is an association of attorneys who have won seven-figure verdicts and settlements on behalf of their clients. This group is one of the most prestigious organizations for trial lawyers in the United States as fewer than 1% of U.S. lawyers have qualified as members.

 

In addition to great results for his clients, Dallas has also gained the respect of his peers for his ethics, ability, and professionalism. Dallas has received the highest level of distinction of an AV ® rated attorney by Martindale-Hubbell, which recognizes Dallas as possessing “Very High-Preeminent” legal ability with “Very High” ethical standards.

Yisroel Szpigiel, Of-Counsel

Yisroel Szpigiel

Of-Counsel States Licensed: NY, NJ  
Yisroel Szpigiel is a NY/NJ corporate attorney focused on outside general counsel and commercial transactions. With nearly a decade of experience managing law firms, he represents entrepreneurs, investors, and some of New York’s largest real estate developers in matters ranging across the full business lifecycle– from entity formation and early stage growth to day-to-day commercial contracting to complex financings, acquisitions, and strategic exits. He has closed over $100 million in transactions and is known for practical, business-first legal guidance that protects clients while keeping deals moving. 
 
Since joining LumaLex Law as Managing Partner January 2025, Yisroel has grown the firms Commercial Transactional and Real Estate Practices, and has started the firms MSO practice, focusing on private equity healthcare rollups. Yisroel is best known as a “problem solver”, with the ability to turn complex problems into workable solutions. He was twice named as a Super Lawyers New York Rising Star in 2024 and 2025, in the practice areas of Business Law, Real Estate, Mergers and Acquisitions, and Plaintiff’s Personal Injury.

In addition to his work with LumaLex Law and serving as trusted outside counsel to businesses in a wide range of industries, he has been recognized by community leaders with citations and awards. Yisroel earned his undergraduate degree from Rutgers University and his J.D. from Hofstra University School of Law, where he later returned as an adjunct professor. Outside the office, he enjoys golf, pickleball, and traveling with his wife and three children. 
Tom Dean | Of-Counsel

Tom Dean

Of-Counsel 
States Licensed: AZ

 

Tom Dean has been an attorney advocate for nationwide cannabis policy reform for over 25 years. As Legal Director for the National Organization for the Reform of Marijuana Laws (NORML) he initiated, managed, and litigated important cannabis related cases of national importance to the cannabis industry/community. In that capacity, he also coordinated the efforts of the NORML Legal Committee (lifetime member) and NORML Amicus Committee (former chair) in key cases throughout the U.S.  In 2015 the organization recognized his successful advocacy by inducting him into the NORML Distinguished Counsel’s Circle. He remains an active member of the NORML Legal Committee.

In 2016, Tom received the President’s Commendation award from the Arizona Attorneys for Criminal Justice (AACJ). In 2020, Tom received a Lifetime Achievement Award from the Errl Cup, a medical marijuana event producer which includes Arizona’s premier cannabis awards festival (30,000 attendees this year).

In 2021, Tom received Mikel Weiser Lifetime Achievement Award from Arizona’s Marijuana Industry Trade Association (MITA). Most recently, in 2023, Tom was honored by NORML with its Al Horn Award, which the organization awards to an attorney each year to in “recognition of a lifetime of ceaseless work to advance the cause of justice” in cannabis law.

Tom was a founding member of the Arizona Cannabis Bar Association (ACBA), an organization that seeks to educate lawyers and the public of the many unique aspects of cannabis law and emerging cannabis related areas of practice. He continues to serve on the board of ACBA. Outside of his practice, Tom enjoys, among other things, presenting at cannabis related seminars and conferences for lawyers and the public.

Josh Sanderlin | Of Counsel

Joshua Sanderlin

Of Counsel
States Licensed: MD, D.C.

Joshua Sanderlin is an experienced cannabis attorney and government affairs expert barred in Maryland and the District of Columbia. He has worked in the cannabis industry since 2013. At that time, he was an attorney and lobbyist at a large, global law firm. His experience working with clients in the earliest legal cannabis market in the U.S. sparked his interest in the field and motivated him to leave big law for the world of cannabis.

Since then, he has served as a lawyer and consultant to clients working in markets across the country, including seven states and the District of Columbia. His experience has given him a wide breadth of knowledge on issues touching the industry and, just as importantly, expanded his network to include experts from all across the industry. Having worked on cannabis issues in a variety of settings, Joshua understands that the industry is best served by specialized services.

Edgar J. Asebey | Of Counsel

Edgar J. Asebey

Of Counsel
States Licensed: FL, D.C.

 

Edgar J. Asebey is a regulatory and transactional attorney with over two decades of experience in federal regulation of pharmaceutical, biotechnology, medical device, food, dietary supplement and cosmetics companies. Since 2015, he has been working on Cannabis-related matters and transactions and since 2018 he has provide regulatory compliance, business transactional, venture finance and international trade services to hemp/CBD companies. Edgar brings a wealth of knowledge and over 20 years of experience to life science, Cannabis and hemp/CBD clients who require novel solutions to complex issues.

Edgar practices before the Food and Drug Administration (FDA), United States Department of Agriculture (USDA), Customs and Border Protection (CBP), Environmental Protection Agency (EPA), and the Federal Trade Commission (FTC), representing client companies on regulatory compliance, product approval/registration and FDA enforcement defense matters. He also assists clients with international and domestic business transactions, IP licensing, venture finance, trademark protection and import/export matters.

Edgar studied molecular biology at the University of Chicago and spent 5 years working in molecular biology research laboratories at the University of Chicago and the University of Illinois.  Early in his career he served as a Patent and Licensing Advisor to the Natural Products Branch of the National Cancer Institute at the National Institutes of Health (NIH).  He founded and served as president of Andes Pharmaceuticals, Inc., a natural products drug discovery company, from 1994 to 2000 and has served as in-house counsel to two life sciences companies. Most recently he was an equity partner in the Health Care & Life Sciences Practice Group at Jones Day. Edgar is currently a partner at Keller Asebey Life Science Law, PLLC.

While Edgar holds licenses to practice law in Florida and Washington, D.C. he can represent clients on federal regulatory matters in all 50 states.  He is a member of the American Bar Association (Section on Administrative Law & Regulatory Practice: Food and Drug Committee and International Committee), Food & Drug Law Institute (FDLI), Dade County Bar Association, and BioFlorida.

Dan Miller Head-Shot | Of-Counsel

Dan Miller

Of-Counsel
States Licensed: CA

Dan Miller, Esq., with over 15 years of experience in cannabis law and a growing expertise in psychedelics, is a staunch advocate for honoring both traditional and evolving regulated uses of these substances. A Vermont Law School alumnus (Class of 1998), he holds a J.D. and a Master’s in Environmental Law and Policy.

Before his foray into the world of entheogenic medicines, Dan honed his skills as a trial attorney with a focus on both criminal and civil cases. His passion for and in-depth understanding of cannabis and psychedelic substances redirected his career path, leading him to develop a niche practice area that has since become his hallmark.

Dan’s role in the cannabis industry is not just as a lawyer, but as a partner in his clients’ endeavors. He oversees all aspects of business development, from structural planning and licensing to adapting to dynamic legal landscapes. His strategic insights have been key in securing licenses, operational planning, and facilitating interstate business growth.

Dan continues to serve as outside general counsel for various businesses, leveraging his litigation background to offer comprehensive legal advice.

As the legal landscape continues to evolve, Dan Miller remains a steadfast and knowledgeable advocate, committed to bridging the gap between traditional use and modern regulatory frameworks in the world of cannabis and psychedelics.

States Licensed: CA

Christina Jaramillo | Junior Associate

Christina Jaramillo

Junior Associate
States Licensed: FL, CA

Christina Jaramillo is an Associate Attorney at LumaLex Law and an active member of The Florida Bar. Christina’s primary focus has been in the practice area of business transactions. Christina has legal experience drafting and reviewing various sales and services agreements, completing entity filings and EIN applications, drafting corporate governance documents and business plans, preparing franchise disclosure documents, drafting and reviewing commercial and residential lease agreements, assisting with mergers and acquisitions, preparing demand letters, working on estate plans and probate matters, and trademarks. Prior to joining LumaLex Law, Christina led the estate planning department at The Law For All, P.A.

Christina is the daughter of two Latinx immigrants, the youngest of five siblings, and the first member of her immediate family to graduate from college. In 2017, after just three short years on campus, Christina received her Bachelor of Science in Political Science, magna cum laude, from Florida State University, where she also minored in Economics. Christina received her Juris Doctor, magna cum laude, from the University of Miami School of Law in 2020.

While attending the University of Miami School of Law, Christina received several honors: Christina was nominated to serve as one of two Articles & Comments Editors for the University of Miami International and Comparative Law Review; Christina was a recipient of the Dean’s Certificate of Achievement Award, which is awarded to the top one or two students in the course, in Legal Communications & Research II; and Christina made the Dean’s List twice.

During her time in law school, Christina served as a Fellow and Blog Editor for the Professional Responsibility and Ethics Program (PREP), an intern for the Human Rights Clinic, and a Civil Procedure Dean’s Fellow. Christina was active on campus and engaged in her community because she understood the value in connecting with those around her and serving the needs of her community, which remains true today.

In her free time, Christina can be found at her local comic book shop or vegan bakery. Christina loves to read, stay up to date on popular television shows and movies, watch soccer, and occasionally jog.

Andy Sick | Partner

Andy Sick

Partner
States Licensed: NY, NJ, MI, CT

Andy Sick has been advising businesses, startups, and entrepreneurs for nearly 15 years. He assists clients through every stage of the business life cycle from incorporation and initial growth phases, to maturity with ongoing general counsel services including regulatory compliance and critical commercial transactions, and dissolution. Licensed to practice in New York, New Jersey, and Connecticut, Andy is the attorney responsible for the firm’s practice in these states.

At Mr. Cannabis Law, Andy represents various cannabis-related businesses on such matters as corporate structuring, licensing, and financing. He navigates clients through the constantly changing sea of cannabis rules and regulations. Andy handles marijuana license applications, business plans, and operating procedures for dispensaries, cultivators, nurseries, manufacturers, distributors, wholesalers, delivery services, and testing facilities. For the firm’s hemp industry clients, Andy helps obtain hemp licenses and maintain compliance with federal and state regulations. In the psychedelic space, Andy has served as a legal advisor to numerous non-profits, companies, and organizations including such groups as Decriminalize Nature and the Native American Church.

Andy began his legal career at boutique law firms serving as outside general counsel to businesses and representing clients in complex commercial litigation. Whether representing a three-person video game startup or a multinational spent nuclear fuel storage company, Andy worked directly with company presidents and other executives to develop and implement corporate legal strategies. Subsequently, he founded several startups, including a legal technology company that adapted artificial intelligence and virtual reality for use in the law. In addition to working with Mr. Cannabis Law, Andy has his own law firm, Sick Legal, which provides business and commercial transactional services to a range of clients.

During law school, Andy worked at the U.S. Justice Department’s Office of Consumer Litigation, the U.S. Attorney’s Office for the Northern District of New York, and for President Joe Biden when he served on the U.S. Senate Judiciary Committee

Andy is responsible for firm operations in New York, New Jersey, Michigan, and Connecticut 

Amanda Raychev| Partner

Amanda Raychev

Partner
States Licensed: FL

Amanda Raychev is a Partner at LumaLex Law with more than 15 years of experience advising entrepreneurs, business owners, and investors on complex corporate and transactional matters.  Her practice focuses on corporate structuring, mergers and acquisitions, corporate governance, and regulatory compliance, with particular experience representing businesses operating in highly regulated and emerging industries. 

Amanda regularly serves as outside corporate counsel to companies throughout all stages of the business lifecycle.  She advises clients on entity formation and complex ownership structures, capital raises and other financing transactions, structuring partner admissions and buyouts, acquisitions, and dispositions, corporate governance, and day-to-day business matters.  Her work also includes negotiating and drafting a wide range of commercial agreements, including employment and independent contractor agreements, vendor and service agreements, operating and shareholder agreements, financing documents, and other contracts essential to her clients’ operations and growth. 

A significant portion of Amanda’s practice involves businesses navigating complex or evolving regulatory environments.  She has extensive experience advising cannabis companies on licensing, regulatory compliance, corporate structuring, and transactions, including assisting clients with competitive cannabis license applications.  She also represents business and entrepreneurs in other emerging and highly regulated industries, including alternative health and wellness, telehealth, and healthcare related businesses, where corporate and transactional decisions often intersect with complicated regulatory considerations.  Amanda also serves on the leadership team of CannabisLAB, a professional organization focused on education, networking, and collaboration within the legal cannabis industry. 

Amanda also advises nonprofit and mission-driven organizations, including 501(c)(3) nonprofit organizations and churches, on formation, governance, commercial arrangements, and ongoing operations. Her experience working with both traditional businesses and organizations operating in developing areas of law allows her to help clients structure creative business models while identifying and managing the legal and regulatory risks that accompany them. 

Prior to joining LumaLex Law, Amanda served as senior in-house counsel for a fintech company, where she built and managed its legal department and developed innovative resolution and recovery strategies.  She also served as in-house counsel to a private investment firm, handling transactions involving secured lending, Debtor-in-possession financing, investment fund matters, and municipal bond financing.  Earlier in private practice, Amanda led the transactional department of a South Florida law firm, advising businesses on corporate structuring, mergers and acquisitions, asset protection, succession planning, and commercial contracts.  

Amanda has been a member of The Florida Bar since 2010 and is admitted to practice before the U.S. District Courts and U.S. Bankruptcy Courts for the Southern, Middle, and Northern Districts of Florida.  She is actively involved in The Florida Bar’s Solo & Small Firm Section and currently serves as Secretary of the Section. 

Outside of the office, Amanda and her husband recently welcomed a baby girl to their family.  An avid ocean lover, she is happiest on or under the water and particularly enjoys scuba diving, boating, and travelling. 

Dustin Robinson | Managing Partner

DUSTIN ROBINSON

Founding Partner
States Licensed: FL

Dustin Robinson is the Founding Partner of LumaLex Law. Licensed in Florida as an Attorney, Certified Public Accountant, and Real Estate Agent, Robinson brings a rare, fully integrated legal–financial–business perspective to every engagement. His practice focuses on corporate structuring, regulatory strategy, transactions, capital formation, and high-stakes commercial litigation for growth-stage and emerging-market companies across a wide range of industries.

Before launching LumaLex Law, Robinson trained at two of the world’s most respected professional services firms—Deloitte and Holland & Knight—where he developed deep technical grounding in tax, corporate law, and complex commercial matters. He then left traditional practice to become an operator himself, applying his legal and accounting background to help run a multi-state manufacturing company that he helped grow to nearly $50 million in revenue. That experience shaped his core philosophy: great legal advice must be practical, entrepreneurial, and grounded in the realities of building and scaling real businesses.

Robinson is not only an advisor to entrepreneurs—he is one. In addition to LumaLex Law, he is the founder of multiple ventures, including Iter Investments , a venture capital fund backing frontier technologies and next-generation healthcare platforms; and Nucleus, a venture studio focused on launching digital and data-driven assets in emerging markets. Across his legal and investment platforms, Robinson has worked with founders operating in biotech, neurotech, telehealth, psychedelics, cannabis, fintech, real estate, digital media, AI-driven platforms, and other highly regulated or rapidly evolving sectors.

Widely regarded as a trailblazer in emerging industries, Robinson has played a leading role in shaping legal and commercial frameworks for novel business models long before they became mainstream. He has served as lead counsel in several high-profile commercial disputes, including the widely covered Shohei Ohtani 50–50 baseball litigation, and is frequently sought out for matters involving regulatory gray zones, innovative deal structures, and first-of-their-kind ventures.

Robinson also served on the Board of Directors of Clairvoyant Therapeutics, a biotechnology company that was advancing psilocybin-based treatments for alcohol use disorder through FDA clinical trials. He has advised and represented numerous venture-backed companies, founders, and investment vehicles operating at the intersection of science, technology, regulation, and capital markets.

Beyond legal practice and investing, Robinson is deeply involved in thought leadership and ecosystem-building. He created and moderates a long-running monthly panel series at Soho Beach House Miami, convening founders, physicians, scientists, investors, and cultural leaders to discuss innovation, wellness, and frontier technologies. Past guests have included NBA Champion Lamar Odom, NHL star Daniel Carcillo, and other prominent figures across business and entertainment.

Robinson has been regularly profiled and featured as an expert in major media outlets, including Bloomberg News, Forbes, The Wall Street Journal, INSIDER, VICE, The Miami Herald, Authority Magazine, Thrive Global, Benzinga, and others. He is a frequent speaker at global industry conferences and private founder and investor forums.

A triple Gator, Robinson earned his Bachelor’s in Accounting, Master’s in Accounting, and Juris Doctor from the University of Florida.

Today, Robinson’s work sits at the intersection of law, entrepreneurship, and capital formation. He is known for helping founders think bigger, structure smarter, and move faster—while staying compliant, investable, and defensible. His mission is simple: to help entrepreneurs build category-defining companies in industries that don’t yet have a playbook.